Early research (Phase 1)Study completedNCT00393965What this trial is testingMultiple Dose Study of MPC-6827 in Subjects With Refractory Brain MetastasesWho this might be right forBrain Neoplasms Myrexis Inc. 18
Not applicableUnknownNCT03787667What this trial is testingApplication of Radiomics in Precise Preoperative Diagnosis and Prognsis Evaluation of Colorectal Cancer.Who this might be right forColorectal Cancer Stage I-IV Fudan University 2,000
Large-scale testing (Phase 3)Study completedNCT00053807What this trial is testingInterleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC 96
Testing effectiveness (Phase 2)Study completedNCT00727831What this trial is testingMethotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaWho this might be right forChemotherapeutic Agent ToxicityLymphomaMucositis+1 more University College, London 4
Not applicableStudy completedNCT01430637What this trial is testingStudying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1Who this might be right forSarcoma Children's Oncology Group 20
Early research (Phase 1)Study completedNCT00441207What this trial is testingStudy of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid TumorsWho this might be right forCancer Midwestern Regional Medical Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562311What this trial is testingChidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial CarcinomaWho this might be right forBladder Cancer Stage IV Sun Yat-sen University 45
Large-scale testing (Phase 3)Active Not RecruitingNCT05933577What this trial is testingA Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)Who this might be right forMelanoma Merck Sharp & Dohme LLC 1,089
Early research (Phase 1)Study completedNCT03095781What this trial is testingPembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerWho this might be right forColorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Colorectal Carcinoma+12 more Emory University 47
Testing effectiveness (Phase 2)Study completedNCT00006081What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00722072What this trial is testingSorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor TherapyWho this might be right forBreast Cancer OHSU Knight Cancer Institute 12
Large-scale testing (Phase 3)Study completedNCT00423475What this trial is testingRadiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerWho this might be right forProstate Cancer UNICANCER 743
Not applicableEnded earlyNCT00898430What this trial is testingBiomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT02180867What this trial is testingRadiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryWho this might be right forAlveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more National Cancer Institute (NCI) 140
Large-scale testing (Phase 3)WithdrawnNCT00403182What this trial is testingChemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWho this might be right forBreast Cancer Technical University of Munich
Testing effectiveness (Phase 2)Study completedNCT01296113What this trial is testingChemotherapy for Lung Cancer in HIV-positive PatientsWho this might be right forNon-small Cell Lung CancerHiv-positive Intergroupe Francophone de Cancerologie Thoracique 61
Testing effectiveness (Phase 2)Looking for participantsNCT05530057What this trial is testingEribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast CancerWho this might be right forAdvanced Breast Cancer Seoul National University Hospital 180
Testing effectiveness (Phase 2)Study completedNCT00923312What this trial is testingTrial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Who this might be right forNon Small Cell Lung Cancer CureVac 46
Testing effectiveness (Phase 2)Ended earlyNCT01116232What this trial is testingSirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00466687What this trial is testingErlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma Vanderbilt-Ingram Cancer Center 34